Cargando…
Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway
Metabolic regulation of cancer cell growth via AMP-activated protein kinase (AMPK) activation is a widely studied strategy for cancer treatment, including leukemias. Recent notions that naturally occurring compounds might have AMPK activity led to the search for nutraceuticals with potential AMPK-st...
Autores principales: | Verrelli, Doriana, Dallera, Luca, Stendardo, Massimo, Monzani, Silvia, Pasqualato, Sebastiano, Giorgio, Marco, Pallavi, Rani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268148/ https://www.ncbi.nlm.nih.gov/pubmed/35807850 http://dx.doi.org/10.3390/nu14132669 |
Ejemplares similares
-
Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia
por: Guo, Naxin, et al.
Publicado: (2019) -
In S. cerevisiae hydroxycitric acid antagonizes chronological aging and apoptosis regardless of citrate lyase
por: Baroni, Maurizio D., et al.
Publicado: (2020) -
Liposome-Mediated Inhibition of Inflammation by Hydroxycitrate
por: Vassallo, Antonio, et al.
Publicado: (2020) -
Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019) -
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
por: Martelli, Alberto M., et al.
Publicado: (2010)